Browsing: Blood
With 44 million Medicare beneficiaries and an annual test costing about $1,000 a year plus expensive scans and biopsies for…
A bone marrow transplant is not a realistic option for most patients. Such transplants are highly invasive and risky, so…
Illumina, the leading maker of gene-sequencing machines, is tiny compared with the tech giants of Silicon Valley. But like Google…
A big market for rare conditionsBetween 2011 and 2013, a small Silicon Valley-based biotech company, Sequenom, tripled in size. The…
Subscribe to Updates
Get the latest news from Michigan Post about world, politics, economics, tech and more
© 2024 Michigan Post. All Rights Reserved.